Quick Answer: What Are PRP Sexual Aesthetic Treatments?
O-Shot (Orgasm Shot) and P-Shot (Priapus Shot) are regenerative aesthetic procedures in which platelet-rich plasma (PRP) derived from the patient's own blood is injected into the female and male genital areas, respectively. The O-Shot delivers growth factors to the clitoris and anterior vaginal wall, improving sexual sensitivity, urinary continence, and vaginal dryness. The P-Shot involves injecting PRP into the corpus cavernosum to enhance erection quality and penile sensitivity. Because both procedures use autologous material (the patient's own biological tissue), the risk of allergic reaction is minimal. Clinical studies are limited, but patient satisfaction is generally reported as high.
PRP Sexual Aesthetics: A New Frontier in Regenerative Medicine
Regenerative medicine is the collective term for approaches that activate the body's own healing capacity. PRP (Platelet Rich Plasma) is the most established of these approaches and has the broadest clinical application range. Used across a wide spectrum from orthopedics to dermatology, from aesthetic medicine to gynecology, PRP has expanded into the field of sexual health over the past decade.
In the context of sexual aesthetics, PRP procedures aim to biologically rejuvenate genital tissues — rather than augmenting them with volume — thereby improving sexual function and comfort. Unlike conventional filler or surgical approaches, entirely autologous material is used; no synthetic substance is introduced into the body.
How Is PRP Prepared? The Source of Growth Factors
The PRP preparation protocol is essentially the same across all applications:
- Blood draw: 10–30 mL of venous blood is drawn from the arm and placed into special tubes containing anticoagulant.
- Centrifugation: Two-stage centrifugation (1st spin: whole blood separation; 2nd spin: PRP concentration) raises platelet concentration to 4–8 times the baseline value.
- PRP fraction separation: Fractionation is performed to yield either leukocyte-rich (LR-PRP) or leukocyte-poor (LP-PRP) product. LP-PRP is generally preferred for sexual aesthetic applications.
- Activation (optional): Platelets may be activated with calcium chloride or thrombin to trigger early release of growth factors.
Key growth factors and their effects on sexual tissue: PDGF (fibroblast proliferation), VEGF (neovascularization, increased genital blood flow), TGF-β (tissue remodeling), EGF (accelerated epithelialization), IGF-1 (nerve and smooth muscle cell support).
O-Shot: Sexual Function and Aesthetics in Women
The O-Shot (Orgasm Shot) is a PRP injection protocol developed and trademarked in 2011 by American urologist Dr. Charles Runels. The procedure involves injecting PRP under local anesthesia into the clitoral root and the anterior vaginal wall (G-spot projection area).
Primary indications:
- Hypoactive sexual desire disorder (HSDD)
- Difficulty achieving orgasm or anorgasmia
- Stress urinary incontinence (mild to moderate)
- Vaginal dryness and dyspareunia (especially postmenopausal)
- Lichen sclerosus (under investigation)
- Aesthetic vaginal rejuvenation
O-Shot Application Protocol
Procedure steps:
- Local anesthesia with topical EMLA cream for 20–30 minutes
- Blood draw and PRP preparation (performed simultaneously)
- Small-volume PRP injection (0.3–0.5 mL) around the clitoral head
- 2–3 mL PRP injection into the anterior vaginal wall (midline of anterior wall)
- Sexual activity restriction for 24 hours post-procedure
Total procedure time: 45–60 minutes. Most patients describe the procedure as causing moderate discomfort; normal daily activities can be resumed immediately afterward.
O-Shot Clinical Data and Efficacy
| Indication | Study Design | Reported Outcome |
|---|---|---|
| Sexual dysfunction | Cohort, n=11 (Runels 2014) | Significant increase in FSFI score; 70%+ satisfaction |
| Stress urinary incontinence | Pilot RCT, n=30 | 50–75% symptom reduction at month 3 |
| Vaginal dryness (menopause) | Observational, n=48 | Significant improvement in VHIS (Vaginal Health Index Score) |
| Lichen sclerosus | Case series, n=12 | Histological improvement and symptom regression |
It should be noted that the quality of evidence remains limited. While large-scale, double-blind randomized trials are still needed, existing data support clinical use.
P-Shot: Erectile Quality and Sexual Function in Men
The P-Shot (Priapus Shot) is a regenerative procedure in which PRP is injected into penile tissue (corpus cavernosum). Primary indications:
- Erectile dysfunction (ED) — particularly vasculogenic or mixed-type
- Peyronie's disease (penile fibrosis / plaque-induced curvature)
- Reduced penile sensitivity
- Sexual recovery support after diabetes or prostate surgery
- General sexual performance enhancement
Experimental and clinical studies have shown that PRP directs corpus cavernosum smooth muscle cells (CCSMC) toward regeneration, supports nitric oxide (NO) signaling critical for erection, and enhances penile blood flow through neovascularization.
P-Shot Clinical Data
| Indication | Study | Outcome |
|---|---|---|
| Erectile dysfunction | RCT, n=60 (Matz 2018) | Significant increase in IIEF score; improved PDE5i response |
| Peyronie's disease | Cohort, n=30 | 34% reduction in plaque size; curvature correction |
| Post-radical prostatectomy ED | Pilot study, n=20 | Contribution to early nerve rehabilitation; increased PDE5i efficacy |
Vaginal Rejuvenation: Laser, PRP, and Filler Combinations
Vaginal rejuvenation increasingly encompasses a broad spectrum of procedures. The role of PRP in this field can be summarized as follows:
- PRP + Hyaluronic Acid filler (Vaginal filler): A combined regenerative + volumetric approach for volume loss in the labia majora or perineal area.
- PRP + Laser (CO2 fractional or Er:YAG): A combination of laser to improve vaginal wall mucosal quality and PRP to accelerate healing; particularly preferred for Genitopelvic Syndrome of Menopause (GSM) treatment.
- PRP + RF (Radiofrequency): Energy-based device + PRP combination for perineal laxity and moderate stress incontinence.
Comparative Application Profile: O-Shot vs. P-Shot
| Feature | O-Shot | P-Shot |
|---|---|---|
| Treatment area | Clitoris + anterior vaginal wall | Corpus cavernosum (2 points) |
| PRP volume | 3–5 mL | 5–10 mL |
| Anesthesia | Topical EMLA (20–30 min) | Local anesthesia + EMLA |
| Procedure duration | 45–60 minutes | 45–60 minutes |
| Onset of first effects | 3–6 weeks | 4–8 weeks |
| Duration of effect | 6–18 months | 6–18 months |
| Number of sessions | 1–3 sessions (3–6 months apart) | 1–3 sessions (3–6 months apart) |
| Downtime | Minimal — 24-hour restriction | Minimal — 24–48-hour restriction |
Contraindications and Safety
PRP sexual aesthetic procedures are generally considered safe. Contraindications include:
- Thrombocytopenia or active bleeding disorder
- Pregnancy and breastfeeding
- Active genital herpes or HPV lesions (active infection in the area)
- Active pelvic inflammatory disease
- Use of anticoagulant medications (requires assessment)
- History of cancer (particularly hormone-sensitive cancers — relative contraindication)
PRP Sexual Aesthetic Treatments at Virtuana Clinic
Virtuana Clinic in Izmit/Kocaeli offers PRP sexual aesthetic treatments under strict confidentiality standards and as part of a comprehensive assessment process. For each patient, a detailed medical history, sexual function questionnaire scoring (FSFI, IIEF), and — where necessary — gynecology or urology consultations are arranged. O-Shot and P-Shot procedures are performed within a holistic sexual health framework, supported by hormonal evaluation, lifestyle analysis, and, where appropriate, combined regenerative protocols.
This service, available to patients from Kocaeli and surrounding provinces, is conducted in a private consultation environment with full confidentiality. The consultation process provides a non-judgmental and comfortable setting for intimate questions.
Frequently Asked Questions
Is the O-Shot painful? It is well tolerated with topical EMLA cream. Most patients report a mild sense of pressure or fullness; significant pain is rare.
Does the O-Shot guarantee a full orgasm? No. Sexual response is multifactorial; psychological, relational, and hormonal components are all determining factors. PRP can improve tissue quality and sensitivity, but it cannot control every dimension of the sexual experience.
Does the P-Shot replace ED medications? No; it is generally considered a complementary approach. It has been reported that using PRP alongside PDE5i medications may enhance drug efficacy.
When do results begin? In both procedures, initial effects begin to be felt within 3–6 weeks; maximum biological effect appears approximately 3 months after treatment.
This article is for informational purposes only. Please consult a qualified physician for treatment decisions.